25th Mar 2026 07:00
|
Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income |
|
| |||||
|
|
| 31 December 2025 |
| 31 December 2024 |
|
|
|
|
| Shs'000 |
| Shs'000 |
|
|
| |||||||
Sales | 5,368,622 | 4,791,692 | |||||
| |||||||
Profit/(loss) before fair value gain in non-current biological assets and income tax |
470,187 |
|
(404,704 |
) | |||
Fair value gain in non-current biological assets | 98,230 | 237,956 | |||||
| |||||||
Profit/(loss) before income tax | 568,417 | (166,748 | ) | ||||
Income tax (charge)/credit | (180,844 | ) | 35,054 | ||||
Operating profit/(loss) for the year | 387,573 | (131,694 | ) | ||||
Other Comprehensive Income: | |||||||
Items that are not reclassified to profit or loss: | |||||||
Remeasurement of post-employment benefit obligations (net of tax) | 3,955 | 1,322 | |||||
Total comprehensive income/(loss) | 391,528 | (130,372 | ) | ||||
| Shs |
| Shs |
|
| ||
Earnings per share (Shs): |
|
|
|
|
| ||
Basic and diluted earnings/(loss) per ordinary share | 19.77 | (6.72 | ) | ||||
Condensed Consolidated Statement of Cash flows |
|
| |||||
|
|
| 31 December 2025 |
| 31 December 2024 |
|
|
|
|
| Shs'000 |
| Shs'000 |
|
|
Cash and cash equivalents at the beginning of the year | 1,106,684 | 1,408,131 | |||||
| |||||||
Net cash generated from operating activities | 853,151 | 474,681 | |||||
Net cash used in investing activities | (268,246 | ) | (138,756 | ) | |||
Net cash used in financing activities | (156,861 | ) | (470,463 | ) | |||
Net increase/(decrease) in cash and cash equivalents | 428,044 | (134,538 | ) | ||||
Net exchange (losses) on foreign currency cash & cash equivalent | (1,525 | ) | (166,909 | ) | |||
Cash and cash equivalents at the end of the year | 1,533,203 | 1,106,684 | |||||
Cash equivalents - Fixed Deposits maturity over three months | 60,000 | - | |||||
Cash and bank balances | 1,593,203 | 1,106,684 | |||||
|
Condensed Consolidated Statement of Financial Position | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 31 December 2025 |
| 31 December 2024 |
|
|
|
|
|
|
|
| Shs'000 |
| Shs'000 |
|
EQUITY | ||||||||||
Share capital | 98,000 | 98,000 | ||||||||
Other reserves | 40,206 | 36,251 | ||||||||
Retained earnings | 5,116,232 | 5,042,259 | ||||||||
Proposed dividends | 313,600 | 156,800 | ||||||||
Total equity | 5,568,038 | 5,333,310 | ||||||||
Non-current liabilities | 1,256,730 | 1,267,964 | ||||||||
6,824,768 | 6,601,274 | |||||||||
REPRESENTED BY | ||||||||||
Non-current assets | 4,072,891 | 4,157,742 | ||||||||
Current assets excluding cash and cash balances | 1,565,481 | 1,651,215 | ||||||||
Cash and bank balances | 1,593,203 | 1,106,684 | ||||||||
Current liabilities | (406,807 | ) | (314,367 | ) | ||||||
Net current assets | 2,751,877 | 2,443,532 | ||||||||
6,824,768 | 6,601,274 | |||||||||
Condensed Consolidated Statement of Changes in Equity |
| |||||||||
| Share capital |
| Other reserves |
| Retained earnings |
| Proposed dividends |
| Total Equity |
|
| Shs'000 |
| Shs'000 |
| Shs'000 |
| Shs'000 |
| Shs'000 |
|
|
|
|
|
|
|
|
|
|
|
|
On 1.1.2025 | 98,000 | 36,251 | 5,042,259 | 156,800 | 5,333,310 | |||||
Profit for the year | - | - | 387,573 | - | 387,573 | |||||
Other comprehensive income | - | 3,955 | - | - | 3,955 | |||||
Dividends - final paid for 2024 | - | - | - | (156,800 | ) | (156,800 | ) | |||
Proposed dividend for 2025 | - | - | (313,600 | ) | 313,600 | - | ||||
| ||||||||||
On 31.12.2025 | 98,000 | 40,206 | 5,116,232 | 313,600 | 5,568,038 | |||||
INDEPENDENT AUDITORS' REPORT ON THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
TO THE SHAREHOLDERS OF KAKUZI PLC
Opinion
The accompanying condensed consolidated financial statements of Kakuzi Plc and its subsidiaries (the "Group"), which comprise the condensed consolidated statement of financial position as at 31 December 2025, and the condensed consolidated statement of profit or loss and other comprehensive income, the condensed consolidated statement of changes in equity and the condensed consolidated statement of cash flows for the year then ended, are derived from the audited financial statements of the Group for the year ended 31 December 2025.
In our opinion, the accompanying condensed consolidated financial statements are consistent, in all material respects, with the audited financial statements of the Group, in accordance with the requirements of the Capital Markets (Securities) (Public Offers, Listings and Disclosures) Regulation, 2002 (''the Regulations'') as applicable to summary financial statements.
Condensed consolidated financial Statements
The condensed consolidated financial statements do not contain all the disclosures required by the IFRS Accounting Standards as issued by the International Accounting Standards Board as applicable to annual financial statements. Reading the condensed consolidated financial statements and the auditors' report thereon, therefore, is not a substitute for reading the audited financial statements of the Group and the auditors' report thereon. The summary financial statements and the audited financial statements do not reflect the effects of events that occurred subsequent to the date of our report on the audited financial statements.
The audited financial statements and our report thereon
We expressed an unmodified audit opinion on the audited financial statements in our report dated 24 March 2026. That report also includes the communication of a key audit matter related to measurement of biological assets. Key audit matters are those matters that in our professional judgement were of most significance in our audit of the financial statements of the current period.
Directors' Responsibility for the condensed consolidated Financial Statements
The directors are responsible for the preparation of the condensed consolidated financial statements in accordance with Capital Markets (Securities) (Public Offers, Listings and Disclosures) Regulation, 2002 (''the Regulations'') as applicable to summary financial statements and for such internal control as the directors determine is necessary to enable the preparation of the condensed consolidated financial statements that are free from material misstatement, whether due to fraud or error.
Auditors' responsibility
Our responsibility is to express an opinion on whether the condensed consolidated financial statements are consistent, in all material respects, with the audited financial statements based on our procedures, which were conducted in accordance with International Standard on Auditing (ISA) 810 (Revised), Engagements to Report on Summary Financial Statements.
The engagement partner responsible for the audit resulting in this independent auditor's report is CPA Fredrick Okwiri, Practicing Certificate No. 1699
For and on behalf of Deloitte & Touche LLP
Certified Public Accountants
Deloitte Place,
Waiyaki Way, Muthangari
P.O Box 40092 - 00100
Nairobi
24 March 2026
Related Shares:
Kakuzi